141 related articles for article (PubMed ID: 26181171)
1. Progesterone Exposure and Breast Cancer Risk: Understanding the Biological Roots.
Joshi PA; Goodwin PJ; Khokha R
JAMA Oncol; 2015 Jun; 1(3):283-5. PubMed ID: 26181171
[No Abstract] [Full Text] [Related]
2. Progesterone and Synthetic Progestin Controversies.
Gompel A; Plu-Bureau G
JAMA Oncol; 2015 Oct; 1(7):987. PubMed ID: 26448287
[No Abstract] [Full Text] [Related]
3. Progesterone and Synthetic Progestin Controversies.
Jordan VC; Maximov PY; Fan P
JAMA Oncol; 2015 Oct; 1(7):986-7. PubMed ID: 26448286
[No Abstract] [Full Text] [Related]
4. Progesterone and Synthetic Progestin Controversies--Reply.
Joshi PA; Goodwin PJ; Khokha R
JAMA Oncol; 2015 Oct; 1(7):987-8. PubMed ID: 26448288
[No Abstract] [Full Text] [Related]
5. Re: Estrogen plus progestin therapy and breast cancer in recently postmenopausal women.
Langer RD
Am J Epidemiol; 2009 Mar; 169(6):784-5; author reply 785-6. PubMed ID: 19208722
[No Abstract] [Full Text] [Related]
6. Women seek alternatives to hormone replacement therapy.
Altern Ther Health Med; 2002; 8(5):27. PubMed ID: 12233798
[No Abstract] [Full Text] [Related]
7. Combination hormone therapy tied to slight increase in breast cancer deaths.
Mayo Clin Womens Healthsource; 2011 Mar; 15(3):3. PubMed ID: 21301403
[No Abstract] [Full Text] [Related]
8. Clinical trials report. Risks and benefits of hormone replacement therapy.
Kotchen TA; Mansour G; Mansour AJ
Curr Hypertens Rep; 2003 Dec; 5(6):483-4. PubMed ID: 14594567
[No Abstract] [Full Text] [Related]
9. [Hormone replacement therapy in menopause].
Breckwoldt M
Dtsch Med Wochenschr; 2003 Feb; 128(8):400. PubMed ID: 12594630
[No Abstract] [Full Text] [Related]
10. Pfizer ordered to pay $103m over hormone drugs and breast cancer.
Tanne JH
BMJ; 2009 Nov; 339():b5085. PubMed ID: 19946002
[No Abstract] [Full Text] [Related]
11. So far, victories are few as breast cancer patients sue Wyeth over hormone therapy.
Twombly R
J Natl Cancer Inst; 2007 Dec; 99(24):1828-9, 1835. PubMed ID: 18073368
[No Abstract] [Full Text] [Related]
12. Combined hormone therapy and breast cancer: a single-edged sword.
Gann PH; Morrow M
JAMA; 2003 Jun; 289(24):3304-6. PubMed ID: 12824214
[No Abstract] [Full Text] [Related]
13. Effects of percutaneous estradiol-oral progesterone versus oral conjugated equine estrogens-medroxyprogesterone acetate on breast cell proliferation and bcl-2 protein in healthy women.
Murkes D; Conner P; Leifland K; Tani E; Beliard A; Lundström E; Söderqvist G
Fertil Steril; 2011 Mar; 95(3):1188-91. PubMed ID: 21067727
[TBL] [Abstract][Full Text] [Related]
14. The estrogen and progestin dilemma: new advice, labeling guidelines.
Bren L
FDA Consum; 2003; 37(2):10-1. PubMed ID: 12715763
[No Abstract] [Full Text] [Related]
15. Failure of estrogen plus progestin therapy for prevention.
Fletcher SW; Colditz GA
JAMA; 2002 Jul; 288(3):366-8. PubMed ID: 12117403
[No Abstract] [Full Text] [Related]
16. NIH workshop tries to create consensus on HRT use.
Randal J
J Natl Cancer Inst; 2003 Jan; 95(1):9-11. PubMed ID: 12509392
[No Abstract] [Full Text] [Related]
17. Postmenopausal hormones: where do we go from here?
Harv Womens Health Watch; 2003 Jan; 10(5):3-4. PubMed ID: 12543588
[No Abstract] [Full Text] [Related]
18. Re.: Postmenopausal hormone use and the risk of nephrolithiasis: results from the Women's Health Initiative Hormone Therapy Trials.
Assimos D
J Urol; 2011 May; 185(5):1749-50. PubMed ID: 22088708
[No Abstract] [Full Text] [Related]
19. Discussing breast cancer and hormone replacement therapy with women.
Batur P; Thacker HL; Moore HC
Cleve Clin J Med; 2002 Nov; 69(11):838, 840, 843-4 passim. PubMed ID: 12430969
[TBL] [Abstract][Full Text] [Related]
20. [Requiem for hormone replacement therapy? This does not apply to modern preparations!].
Lippert TH; Mueck AO
MMW Fortschr Med; 2003 Sep; 145(37):13; author reply 13-4. PubMed ID: 14584434
[No Abstract] [Full Text] [Related]
[Next] [New Search]
